Drug maker AbbVie Inc. continued its pursuit of Shire PLC Wednesday by laying out the rationale for its $46 billion takeover bid, which Shire rejected last week.
from WSJ.com: US Business http://ift.tt/1lTZCQQ
via IFTTT
from WSJ.com: US Business http://ift.tt/1lTZCQQ
via IFTTT
No comments:
Post a Comment